Core One Labs Inc (COOL.CX)
0.185
-0.02
(-7.50%)
CAD |
CNSX |
May 16, 16:00
Core One Labs Enterprise Value: 8.808M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 8.808M |
| May 15, 2024 | 9.515M |
| May 14, 2024 | 9.279M |
| May 13, 2024 | 9.750M |
| May 10, 2024 | 9.986M |
| May 09, 2024 | 9.986M |
| May 08, 2024 | 10.46M |
| May 07, 2024 | 10.22M |
| May 06, 2024 | 8.808M |
| May 03, 2024 | 10.93M |
| May 02, 2024 | 10.93M |
| May 01, 2024 | 10.93M |
| April 30, 2024 | 10.93M |
| April 29, 2024 | 9.279M |
| April 26, 2024 | 9.044M |
| April 25, 2024 | 8.573M |
| April 24, 2024 | 8.573M |
| April 23, 2024 | 8.573M |
| April 22, 2024 | 9.515M |
| April 19, 2024 | 11.16M |
| April 18, 2024 | 9.279M |
| April 17, 2024 | 9.279M |
| April 16, 2024 | 9.750M |
| April 15, 2024 | 9.750M |
| April 12, 2024 | 9.750M |
| Date | Value |
|---|---|
| April 11, 2024 | 9.750M |
| April 10, 2024 | 9.986M |
| April 09, 2024 | 9.986M |
| April 08, 2024 | 11.40M |
| April 05, 2024 | 11.40M |
| April 04, 2024 | 9.750M |
| April 03, 2024 | 10.93M |
| April 02, 2024 | 10.22M |
| April 01, 2024 | 9.279M |
| March 28, 2024 | 9.044M |
| March 27, 2024 | 10.93M |
| March 26, 2024 | 10.93M |
| March 25, 2024 | 8.808M |
| March 22, 2024 | 8.808M |
| March 21, 2024 | 8.808M |
| March 20, 2024 | 8.808M |
| March 19, 2024 | 10.46M |
| March 18, 2024 | 11.40M |
| March 15, 2024 | 11.40M |
| March 14, 2024 | 10.46M |
| March 13, 2024 | 10.46M |
| March 12, 2024 | 11.40M |
| March 11, 2024 | 11.40M |
| March 08, 2024 | 10.69M |
| March 07, 2024 | 10.69M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.640M
Minimum
Jun 04 2020
138.69M
Maximum
Feb 10 2021
27.66M
Average
18.03M
Median
Feb 07 2022
Enterprise Value Benchmarks
| Biocure Technology Inc | 1.448M |
| Nova Mentis Life Science Corp | 2.183M |
| Nanosphere Health Sciences Inc | 0.2445M |
| Lobe Sciences Ltd | 3.658M |
| Algernon Pharmaceuticals Inc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.8407M |
| Revenue (Quarterly) | 0.0937M |
| Total Expenses (Quarterly) | 0.5213M |
| EPS Diluted (Quarterly) | -0.02 |
| Profit Margin (Quarterly) | -897.6% |
| Earnings Yield | -54.05% |
| Normalized Earnings Yield | -39.35 |